Daniel Spratt
University of Michigan
H-index: 65
North America-United States
Top articles of Daniel Spratt
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Patient-reported health-related quality of life (HRQoL) in the randomized FORMULA-509 trial of salvage radiotherapy and 6 months of GnRH agonist with either bicalutamide or … | Karen E Hoffman Paul L Nguyen Dana E Rathkopf Amado J Zurita Daniel Eidelberg Spratt | 2024/2/1 | |
Impact of National Comprehensive Cancer Network Guidelines Inclusion of Level 1 Evidence on Insurance Denial of Care for Randomized Controlled Trial-Eligible Patients with … | Dermatologic Surgery | Bichchau Nguyen Pritesh S Karia Victoria M Hills Robert J Besaw Chrysalyne D Schmults | 2018/4/1 |
PD57-07 IMPACT OF QUALITY IMPROVEMENT INITIATIVE TIED TO VALUE-BASED REIMBURSEMENT METRIC ON SALVAGE THERAPY UTILIZATION AFTER RADICAL PROSTATECTOMY | The Journal of Urology | Arsyad Santosa Apoorv Dhir Kevin Ginsburg Tudor Borza Anna Johnson | 2024/5 |
Expert perspectives on controversies in castration-sensitive prostate cancer management: narrative review and report of the first US prostate cancer conference part 1 | E David Crawford Alan H Bryce Maha H Hussain Neeraj Agarwal Himisha Beltran | 2024/4/1 | |
Interaction of age and benefit of treatment intensification in advanced prostate cancer: An aggregate meta-analysis of 14 randomized trials. | Alicia K Morgans Soumyajit Roy Pedro C Barata Jason R Brown Angela Jia | 2024/2/1 | |
Major complications and adverse events related to use of SpaceOAR hydrogel for prostate cancer radiotherapy | Urology | Jack C Millot Camilo Arenas-Gallo Esther Silver Mollie Goldman Shany Picciotto | 2024/3/6 |
PD42-11 DEVELOPMENT AND VALIDATION OF A MULTIMODAL ARTIFICIAL INTELLIGENCE (MMAI)-DERIVED DIGITAL PATHOLOGY-BASED BIOMARKER PREDICTING METASTASIS FOR RADICAL PROSTATECTOMY … | The Journal of Urology | Todd M Morgan Yi Ren Siyi Tang Wouter Zwerink Emmalyn Chen | 2024/5 |
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2 | Alan H Bryce E David Crawford Neeraj Agarwal Maha H Hussain Himisha Beltran | 2024/4/1 | |
Differential treatment effect on overall survival (OS) based on early prostate-specific antigen (PSA) response in metastatic hormone-sensitive prostate cancer (mHSPC): A … | Soumyajit Roy Shawn Malone Yilun Sun Christopher JD Wallis Amar Upadhyaya Kishan | 2024/2/1 | |
UNDERSTANDING POPULATION-WIDE GENOMIC RISK DISTRIBUTION AND INTEGRATING CLINICAL-GENOMIC RISK FOR PROGNOSITICATION IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER | Urologic Oncology: Seminars and Original Investigations | Udit Singhal Todd M Morgan Ralph Jiang Matthew Schipper Elizabeth Chase | 2024/3/1 |
A population-based study of COVID-19 mortality risk in US cancer patients | JNCI: Journal of the National Cancer Institute | Kyle A Mani Xue Wu Daniel E Spratt Ming Wang Nicholas G Zaorsky | 2024/4/15 |
PD42-03 UNDERSTANDING POPULATION-WIDE GENOMIC RISK DISTRIBUTION AND INTEGRATING CLINICAL-GENOMIC RISK FOR PROGNOSTICATION IN PROSTATE CANCER | The Journal of Urology | Udit Singhal Ralph Jiang Matthew Schipper James Proudfoot Elisabeth Chase | 2024/5 |
Evaluating relugolix for the treatment of prostate cancer in real-world settings of care: the OPTYX study protocol | Daniel E Spratt Tanya Dorff Rana R McKay Benjamin H Lowentritt Mark Fallick | 2024/4 | |
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial | European Urology Oncology | Ashley E Ross Jingbin Zhang Huei-Chung Huang Rikiya Yamashita Jessica Keim-Malpass | 2024/2/1 |
Effect of Concomitant Medications on Treatment Response and Survival in De Novo Metastatic Prostate Cancer: Secondary Analysis of the LATITUDE Study | European Journal of Cancer | Soumyajit Roy Fred Saad Christopher JD Wallis Yilun Sun Daniel E Spratt | 2024/3/1 |
Prostate Cancer, Version 3.2024: Featured Updates to the NCCN Guidelines | Journal of the National Comprehensive Cancer Network | Edward M Schaeffer Sandy Srinivas Nabil Adra Yi An Rhonda Bitting | 2024/4/6 |
Effect of Prior Prostate Directed Local Therapy on Response to Apalutamide in Metastatic Hormone Sensitive Prostate Cancer: A Secondary Analysis of the TITAN Study | European urology | Soumyajit Roy Fred Saad Shawn Malone Neeraj Agarwal Osama Mohamad | 2024/4 |
MP37-05 REAL-WORLD TREATMENT PATTERNS IN PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER LOCAL THERAPY FOR PROSTATE CANCER | The Journal of Urology | Neal D Shore Nasreen Khan Rana R McKay Niculae Constantinovici Guifang Chen | 2024/5 |
Insurance denial of care for randomized controlled trial-eligible patients: incidence and success rate of peer-to-peer authorization in allowing patients to remain trial-eligible | American Journal of Clinical Oncology | Shearwood McClelland III Melissa Brately Raed J Zuhour Yilun Sun Daniel E Spratt | 2024/2/1 |
Artificial intelligence applications in prostate cancer | Atallah Baydoun Angela Y Jia Nicholas G Zaorsky Rojano Kashani Santosh Rao | 2023/6/9 |
Co-Authors
